5. Conclusion
Human cancer is a complex genetic and epigenetic disease. Unlike non- reversible mutagenic events, reversible epigenetic alterations can be considered as potential diagnostic markers and therapeutic targets for cancer therapy [134, 135]. One of the most important epigenetic events in human cancer is aberrant DNA methylation which is known to regulate gene-expression [136]. The genome-wide analysis technologies provide a better understanding of how changes in DNA methylation affect tumor growth and invasiveness. In this review, the common approaches for genome-scale DNA methylation mapping were investigated and the procedure and applications of each method were discussed. The currently applied methods are predominantly performed based upon restriction endonuclease digestion, affinity enrichment and sodium bisulfite conversion, combined with sequencing or array- based methods. The application of each approach depends on the scientific question, power and facility of the method, expected changes in the level of methylation, amount of required DNA, run time and cost [137].